{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T01:11:10Z","timestamp":1773450670858,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"research project plan of Wuxi Health and Family Planning Commission","award":["Q201702"],"award-info":[{"award-number":["Q201702"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s10792-019-01252-z","type":"journal-article","created":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T20:02:27Z","timestamp":1577908947000},"page":"891-899","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Hydrogen sulfide serves as a biomarker in the anterior segment of patients with diabetic retinopathy"],"prefix":"10.1007","volume":"40","author":[{"given":"Yuyi","family":"Han","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengxi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,1]]},"reference":[{"key":"1252_CR1","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.preteyeres.2015.04.003","volume":"48","author":"R Sim\u00f3","year":"2015","unstructured":"Sim\u00f3 R, Hern\u00e1ndez C (2015) Novel approaches for treating diabetic retinopathy based on recent pathogenic evidence. Prog Retinal Eye Res 48:160\u2013180","journal-title":"Prog Retinal Eye Res"},{"issue":"9786","key":"1252_CR2","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0140-6736(11)60614-4","volume":"378","author":"CJ Nolan","year":"2011","unstructured":"Nolan CJ, Damm P, Prentki M (2011) Type 2 diabetes across generations: from pathophysiology to prevention and management. Lancet 378(9786):169\u2013181","journal-title":"Lancet"},{"issue":"15","key":"1252_CR3","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1001\/jama.290.15.2057","volume":"290","author":"NG Congdon","year":"2003","unstructured":"Congdon NG, Friedman DS, Thomas L (2003) Important causes of visual impairment in the world today. JAMA 290(15):2057","journal-title":"JAMA"},{"issue":"3","key":"1252_CR4","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.diabres.2011.10.029","volume":"94","author":"DR Whiting","year":"2011","unstructured":"Whiting DR, Leonor G, Clara W, Jonathan S (2011) IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 94(3):311\u2013321","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"1252_CR5","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2337\/dc11-1909","volume":"35","author":"JWY Yau","year":"2012","unstructured":"Yau JWY, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW (2012) Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 35(3):556\u2013564","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"1252_CR6","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.2337\/diacare.27.2007.S84","volume":"27","author":"DS Fong","year":"2004","unstructured":"Fong DS, Aiello L, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris FL, Klein R (2004) Retinopathy in diabetes. Diabetes Care 27(1):S84","journal-title":"Diabetes Care"},{"issue":"7","key":"1252_CR7","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/IJG.0b013e31824d514a","volume":"22","author":"G Akiko","year":"2013","unstructured":"Akiko G, Masaru I, Toshihiro I, Nanako AK, Yuji T, Yasuhiro I, Mikiko F, Hidenobu T (2013) Frequency and risk factors for neovascular glaucoma after vitrectomy in eyes with proliferative diabetic retinopathy. J Glaucoma 22(7):572\u2013576","journal-title":"J Glaucoma"},{"issue":"1","key":"1252_CR8","first-page":"50","volume":"51","author":"J Hasnan","year":"2010","unstructured":"Hasnan J, Yusof MI, Damitri TD, Faridah AR, Adenan AS, Norbaini TH (2010) Relationship between apoptotic markers (Bax and Bcl-2) and biochemical markers in type 2 diabetes mellitus. Singap Med J 51(1):50\u201355","journal-title":"Singap Med J"},{"issue":"1","key":"1252_CR9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0896-1549(01)00010-4","volume":"15","author":"M Lu","year":"2002","unstructured":"Lu M, Adamis AP (2002) Vascular endothelial growth factor gene regulation and action in diabetic retinopathy. Ophthalmol Clin N Am 15(1):69\u201379","journal-title":"Ophthalmol Clin N Am"},{"issue":"1","key":"1252_CR10","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12886-016-0248-7","volume":"16","author":"L Liu","year":"2016","unstructured":"Liu L, Xu Y, Huang Z, Wang X (2016) Intravitreal ranibizumab injection combined trabeculectomy versus Ahmed valve surgery in the treatment of neovascular glaucoma: assessment of efficacy and complications. BMC Ophthalmol 16(1):65","journal-title":"BMC Ophthalmol"},{"issue":"1","key":"1252_CR11","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/archopht.1996.01100130062010","volume":"114","author":"AP Adamis","year":"1996","unstructured":"Adamis AP, Shima DT, Tolentino MJ, Gragoudas ES, Ferrara N, Folkman J, D'Amore PA, Miller JW (1996) Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate. Arch Ophthalmol 114(1):66\u201371","journal-title":"Arch Ophthalmol"},{"key":"1252_CR12","first-page":"629452","volume":"10","author":"D Gologorsky","year":"2012","unstructured":"Gologorsky D, Thanos A, Vavvas D (2012) Therapeutic interventions against inflammatory and angiogenic mediators in proliferative diabetic retinopathy. Med Inflam 10:629452","journal-title":"Med Inflam"},{"issue":"8","key":"1252_CR13","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1007\/s11064-011-0482-6","volume":"36","author":"M Kulkarni","year":"2011","unstructured":"Kulkarni M, Njie-Mbye YF, Okpobiri I, Zhao M, Opere CA, Ohia SE (2011) Endogenous production of hydrogen sulfide in isolated bovine eye. Neurochem Res 36(8):1540\u20131545","journal-title":"Neurochem Res"},{"key":"1252_CR14","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.bcp.2017.09.010","volume":"149","author":"C Szabo","year":"2018","unstructured":"Szabo C (2018) A timeline of hydrogen sulfide (H2S) research: from environmental toxin to biological mediator. Biochem Pharmacol 149:5\u201319","journal-title":"Biochem Pharmacol"},{"issue":"12","key":"1252_CR15","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1096\/fj.06-6270fje","volume":"20","author":"RCO Zanardo","year":"2006","unstructured":"Zanardo RCO, Brancaleone V, Distrutti E, Fiorucci S, Cirino G, Wallace JL (2006) Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation. FASEB J 20(12):2118\u20132120","journal-title":"FASEB J"},{"issue":"1","key":"1252_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/ars.2008.2282","volume":"12","author":"Y Kimura","year":"2010","unstructured":"Kimura Y, Goto Y, Kimura H (2010) Hydrogen sulfide increases glutathione production and suppresses oxidative stress in mitochondria. Antiox Redox Signal 12(1):1","journal-title":"Antiox Redox Signal"},{"issue":"2","key":"1252_CR17","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.bbrc.2006.10.058","volume":"351","author":"SK Yan","year":"2006","unstructured":"Yan SK, Chang T, Hui W, Wu L, Rui W, Meng QH (2006) Effects of hydrogen sulfide on homocysteine-induced oxidative stress in vascular smooth muscle cells. Biochem Biophys Res Commun 351(2):485\u2013491","journal-title":"Biochem Biophys Res Commun"},{"issue":"96","key":"1252_CR18","doi-asserted-by":"crossref","first-page":"ra72","DOI":"10.1126\/scisignal.2000464","volume":"2","author":"AK Mustafa","year":"2009","unstructured":"Mustafa AK, Gadalla MM, Sen N, Kim S, Mu W, Gazi SK, Barrow RK, Yang G, Wang R, Snyder SH (2009) H2S signals through protein S-sulfhydration. Sci Signal 2(96):ra72","journal-title":"Sci Signal"},{"issue":"10","key":"1252_CR19","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1097\/IAE.0000000000000184","volume":"34","author":"R Ran","year":"2014","unstructured":"Ran R, Du L, Zhang X, Chen X, Fang Y, Li Y, Tian H (2014) Elevated hydrogen sulfide levels in vitreous body and plasma in patients with proliferative diabetic retinopathy. Retina 34(10):2003\u20132009","journal-title":"Retina"},{"issue":"51","key":"1252_CR20","doi-asserted-by":"crossref","first-page":"21972","DOI":"10.1073\/pnas.0908047106","volume":"106","author":"A Papapetropoulos","year":"2009","unstructured":"Papapetropoulos A, Pyriochou A, Altaany Z, Yang G, Marazioti A, Zhou Z, Jeschke MG, Branski LK, Herndon DN, Wang R (2009) Hydrogen sulfide is an endogenous stimulator of angiogenesis. Proc Natl Acad Sci USA 106(51):21972","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"1252_CR21","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1111\/bph.12246","volume":"169","author":"Z Liu","year":"2013","unstructured":"Liu Z, Han Y, Li L, Lu H, Meng G, Li X, Shirhan M, Peh MT, Xie L, Zhou S (2013) The hydrogen sulfide donor, GYY4137, exhibits anti-atherosclerotic activity in high fat fed apolipoprotein E\u2212\/\u2212 mice. Br J Pharmacol 169(8):1795\u20131809","journal-title":"Br J Pharmacol"},{"issue":"250","key":"1252_CR22","first-page":"2371","volume":"18","author":"J Li","year":"2012","unstructured":"Li J, Wang P, Yu S, Zheng Z, Xu X (2012) Calcium entry mediates hyperglycemia-induced apoptosis through Ca(2+)\/calmodulin-dependent kinase II in retinal capillary endothelial cells. Mol Vis 18(250):2371","journal-title":"Mol Vis"},{"issue":"4","key":"1252_CR23","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.exer.2006.04.001","volume":"83","author":"C Persa","year":"2006","unstructured":"Persa C, Osmotherly K, Chen CW, Moon S, Louabcd MF (2006) The distribution of cystathionine \u03b2-synthase (CBS) in the eye: Implication of the presence of a trans-sulfuration pathway for oxidative stress defense. Exp Eye Res 83(4):817\u2013823","journal-title":"Exp Eye Res"},{"issue":"2","key":"1252_CR24","first-page":"158","volume":"505","author":"WP Winnie","year":"2010","unstructured":"Winnie WP, Renata S, Nina F, Jan PK, William DE (2010) Comparative localization of cystathionine beta-synthase and cystathionine gamma-lyase in retina: differences between amphibians and mammals. J Comp Neurol 505(2):158\u2013165","journal-title":"J Comp Neurol"},{"issue":"11","key":"1252_CR25","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.niox.2014.05.014","volume":"41","author":"ML Lo Faro","year":"2014","unstructured":"Lo Faro ML, Fox B, Whatmore JL, Winyard PG, Whiteman M (2014) Hydrogen sulfide and nitric oxide interactions in inflammation. Nitric Oxide Biol Chem 41(11):38","journal-title":"Nitric Oxide Biol Chem"},{"key":"1252_CR26","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.niox.2014.01.002","volume":"41","author":"H Kimura","year":"2014","unstructured":"Kimura H (2014) The physiological role of hydrogen sulfide and beyond. Nitric Oxide 41:4\u201310","journal-title":"Nitric Oxide"},{"issue":"10","key":"1252_CR27","first-page":"2408","volume":"42","author":"T Qaum","year":"2001","unstructured":"Qaum T, Xu Q, Joussen AM, Clemens MW, Qin W, Miyamoto K, Hassessian H, Wiegand SJ, Rudge J, Yancopoulos GD (2001) VEGF-initiated blood-retinal barrier breakdown in early diabetes. Investig Ophthalmol Visual Sci 42(10):2408","journal-title":"Investig Ophthalmol Visual Sci"},{"issue":"7","key":"1252_CR28","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1167\/iovs.15-18555","volume":"57","author":"D Gersztenkorn","year":"2016","unstructured":"Gersztenkorn D, Coletta C, Zhu S, Ha Y, Liu H, Tie H, Zhou J, Szabo C, Zhang W, Motamedi M (2016) Hydrogen sulfide contributes to retinal neovascularization in ischemia-induced retinopathy. Invest Ophthalmol Vis Sci 57(7):3002\u20133009","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"1252_CR29","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.neulet.2010.08.068","volume":"485","author":"Y Liu","year":"2010","unstructured":"Liu Y, Zou LP, Du JB, Wong V (2010) Electro-acupuncture protects against hypoxic-ischemic brain-damaged immature rat via hydrogen sulfide as a possible mediator. Neurosci Lett 485(1):74\u201378","journal-title":"Neurosci Lett"},{"issue":"3","key":"1252_CR30","doi-asserted-by":"crossref","first-page":"810","DOI":"10.3892\/ijmm.2014.2059","volume":"35","author":"G Qingbo","year":"2015","unstructured":"Qingbo G, Wen L, Yuantao L, Youfei F, Xiaolei W, Chunxiao Y, Yuan Z, Shunke W, Jia L, Jiajun Z (2015) High glucose induces the release of endothelin-1 through the inhibition of hydrogen sulfide production in HUVECs. Int J Mol Med 35(3):810","journal-title":"Int J Mol Med"},{"issue":"1","key":"1252_CR31","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/157339909787314239","volume":"5","author":"RF Monica","year":"2009","unstructured":"Monica RF, Virgil A, Kerrison JB, Jablon EP (2009) Ranibizumab for diabetic retinopathy. Curr Diabetes Rev 5(1):47\u201351","journal-title":"Curr Diabetes Rev"},{"issue":"1623","key":"1252_CR32","first-page":"1734","volume":"19","author":"D Ning","year":"2013","unstructured":"Ning D, Bing X, Bingsong W, Liqun C (2013) Study of 27 aqueous humor cytokines in patients with type 2 diabetes with or without retinopathy. Mol Vis 19(1623):1734\u20131746","journal-title":"Mol Vis"},{"issue":"1","key":"1252_CR33","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ophtha.2012.07.038","volume":"120","author":"JW Miller","year":"2013","unstructured":"Miller JW, Couter JL, Strauss EC, Ferrara N (2013) Vascular endothelial growth factor a in intraocular vascular disease. Ophthalmology 120(1):106\u2013114","journal-title":"Ophthalmology"},{"issue":"7","key":"1252_CR34","first-page":"736","volume":"87","author":"J Yanrong","year":"2010","unstructured":"Yanrong J, Xiaoying L, Xiaoxin L, Yong T, Kai W (2010) Analysis of the clinical efficacy of intravitreal bevacizumab in the treatment of iris neovascularization caused by proliferative diabetic retinopathy. Acta Ophthalmol 87(7):736\u2013740","journal-title":"Acta Ophthalmol"},{"issue":"4","key":"1252_CR35","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/IAE.0b013e3182721153","volume":"33","author":"OH Ababneh","year":"2013","unstructured":"Ababneh OH, Yousef YA, Gharaibeh AM, Ameerh MA, Abu A-Y, Bdour MD (2013) Intravitreal bevacizumab in the treatment of diabetic ocular neovascularization. Retina 33(4):748\u2013755","journal-title":"Retina"},{"issue":"9","key":"1252_CR36","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1001\/archophthalmol.2012.1043","volume":"130","author":"MS Ip","year":"2012","unstructured":"Ip MS, Amitha D, Jill JH, Pamela W, Ehrlich JS (2012) Long-term effects of ranibizumab on diabetic retinopathy severity and progression. Arch Ophthalmol 130(9):1145","journal-title":"Arch Ophthalmol"},{"key":"1252_CR37","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.niox.2014.11.010","volume":"46","author":"B Gemici","year":"2015","unstructured":"Gemici B, Elsheikh W, Feitosa KB, Costa SKP, Muscara MN, Wallace JL (2015) H2S-releasing drugs: anti-inflammatory, cytoprotective and chemopreventative potential. Nitric Oxide 46:25\u201331","journal-title":"Nitric Oxide"},{"issue":"9","key":"1252_CR38","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1089\/ars.2009.2945","volume":"12","author":"MJ Wang","year":"2010","unstructured":"Wang MJ, Cai WJ, Li N, Ding YJ, Chen Y, Zhu YC (2010) The hydrogen sulfide donor NaHS promotes angiogenesis in a rat model of hind limb ischemia. Antiox Redox Signal 12(9):1065\u20131077","journal-title":"Antiox Redox Signal"},{"issue":"50","key":"1252_CR39","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0306-9877(98)90217-1","volume":"50","author":"MF Mccarty","year":"1998","unstructured":"Mccarty MF (1998) Nitric oxide deficiency, leukocyte activation, and resultant ischemia are crucial to the pathogenesis of diabetic retinopathy\/ neuropathy\u2014preventive potential of antioxidants, essential fatty acids, chromium, ginkgolides, and pentoxifylline. Med Hypotheses 50(50):435\u2013449","journal-title":"Med Hypotheses"},{"issue":"5","key":"1252_CR40","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.2353\/ajpath.2010.091062","volume":"176","author":"TS Kern","year":"2010","unstructured":"Kern TS, Yunpeng D, Miller CM, Hatala DA, Levin LA (2010) Overexpression of Bcl-2 in vascular endothelium inhibits the microvascular lesions of diabetic retinopathy. Am J Pathol 176(5):2550\u20132558","journal-title":"Am J Pathol"},{"issue":"5","key":"1252_CR41","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.neuint.2012.12.010","volume":"62","author":"Y-Y Liu","year":"2013","unstructured":"Liu Y-Y, Nagpure BV, Wong PTH, Bian J-S (2013) Hydrogen sulfide protects SH-SY5Y neuronal cells against d-galactose induced cell injury by suppression of advanced glycation end products formation and oxidative stress. Neurochem Int 62(5):603\u2013609","journal-title":"Neurochem Int"},{"issue":"1","key":"1252_CR42","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.freeradbiomed.2006.03.021","volume":"41","author":"GS Oh","year":"2006","unstructured":"Oh GS, Pae HO, Lee BS, Kim BN, Kim JM, Kim HR, Jeon SB, Jeon WK, Chae HJ, Chung HT (2006) Hydrogen sulfide inhibits nitric oxide production and nuclear factor-\u03baB via heme oxygenase-1 expression in RAW264.7 macrophages stimulated with lipopolysaccharide. Free Rad Biol Med 41(1):106\u2013119","journal-title":"Free Rad Biol Med"},{"issue":"5","key":"1252_CR43","doi-asserted-by":"crossref","first-page":"e004093","DOI":"10.1161\/JAHA.112.004093","volume":"1","author":"SC Bir","year":"2012","unstructured":"Bir SC, Kolluru GK, Mccarthy P, Shen X, Pardue S, Pattillo CB, Kevil CG (2012) Hydrogen sulfide stimulates ischemic vascular remodeling through nitric oxide synthase and nitrite reduction activity regulating hypoxia-inducible factor-1\u03b1 and vascular endothelial growth factor-dependent angiogenesis. J Am Heart Assoc 1(5):e004093","journal-title":"J Am Heart Assoc"},{"issue":"9","key":"1252_CR44","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1248\/bpb.33.1550","volume":"33","author":"X Liu","year":"2010","unstructured":"Liu X (2010) Hypoxia-inducible factor-1\u03b1 is involved in the pro-angiogenic effect of hydrogen sulfide under hypoxic stress. Biol Pharm Bull 33(9):1550\u20131554","journal-title":"Biol Pharm Bull"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-019-01252-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10792-019-01252-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-019-01252-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,9]],"date-time":"2022-10-09T18:16:30Z","timestamp":1665339390000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10792-019-01252-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,1]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["1252"],"URL":"https:\/\/doi.org\/10.1007\/s10792-019-01252-z","relation":{},"ISSN":["0165-5701","1573-2630"],"issn-type":[{"value":"0165-5701","type":"print"},{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,1]]},"assertion":[{"value":"12 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest regarding the publication of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}